financetom
Business
financetom
/
Business
/
Western Union To Acquire Intermex For $500 Million: IMXI Stock Surges 54%, WU Gains Over 1% In Monday Premarket
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Western Union To Acquire Intermex For $500 Million: IMXI Stock Surges 54%, WU Gains Over 1% In Monday Premarket
Aug 11, 2025 2:11 AM

In a strategic move to expand its presence in Latin America, Western Union Co. ( WU ) has announced the acquisition of Intermex for approximately $500 million.

Western Union To Acquire Intermex in $16-Per-Share Deal

Western Union ( WU ) revealed its plans to acquire Intermex, a U.S.-based company specializing in payment transfers to Latin America and the Caribbean, on Sunday. The acquisition is set to bolster Western Union’s position in the high-growth Latin American markets.

Check out the current price of WU stock here.

Under the deal, Western Union ( WU ) will pay $16 per Intermex share, a premium of more than 70% over Friday's closing price of $9.28. The transaction is expected to boost Western Union's ( WU ) adjusted earnings per share by over $0.10 in its first full year post-closing.

Intermex, serving around 6 million customers, will give Western Union ( WU ) access to its strong digital platforms and capabilities. The deal is expected to deliver $30 million in annual run-rate cost savings within two years.

SEE ALSO: Donald Trump’s 401(k) Executive Order Brings Major Changes — and Potential Risks for Your Retirement

Western Union Eyes Growth Despite Earnings Miss

Western Union’s decision to acquire Intermex comes at a time when the company has been exploring new avenues for growth. Earlier in July, Western Union ( WU ) CEO Devin McGranahan said that the company was considering enabling customers to buy, sell, and store stablecoins, marking a significant step towards the convergence of traditional money transfer firms and blockchain-based digital assets.

However, Western Union’s second-quarter earnings, reported later that month, fell short of analyst expectations. The company posted quarterly earnings of 42 cents per share, missing the analyst consensus estimate of 44 cents per share.

Western Union's ( WU ) P/E ratio is below the Financial Services industry average of 47.12. While this could suggest the stock may underperform its peers, it might also indicate that the stock is undervalued.

According to Benzinga Edge Stock Rankings, Western Union ( WU ) has a growth score of 60.08% and a value rating of 46.85%. Click here to see how it compares to other leading financial services companies.

IMXI stock jumped 54% in Monday's premarket trading. Western Union ( WU ) shares also rose, gaining more than 1%, according to data from Benzinga Pro.

READ MORE:

What’s Fueling PayPal’s Post-Earnings Skepticism?

Image via Shutterstock

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher?
Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher?
Oct 17, 2024
Biodexa Pharmaceuticals Plc ( BDRX ) shares are soaring in Tuesday’s after-hours session following the company’s announcement that it was granted an extension to demonstrate compliance with Nasdaq listing requirements. What Happened: Biodexa announced Tuesday the Nasdaq Hearings Panel approved the company’s request for an extension to demonstrate compliance with the $1 minimum bid price requirement for continued listing. The company announced...
BRIEF-Point72 Asset Management, L.P. Reports 6.2% Passive Stake In ATYR Pharma As Of Oct 14 - SEC Filing
BRIEF-Point72 Asset Management, L.P. Reports 6.2% Passive Stake In ATYR Pharma As Of Oct 14 - SEC Filing
Oct 17, 2024
Oct 15 (Reuters) - aTyr Pharma Inc ( ATYR ): * POINT72 ASSET MANAGEMENT, L.P. REPORTS 6.2% PASSIVE STAKE IN ATYR PHARMA AS OF OCT 14 - SEC FILING Source text for Eikon: Further company coverage: ...
New York Bancorp changes name to Flagstar Financial
New York Bancorp changes name to Flagstar Financial
Oct 17, 2024
Oct 15 (Reuters) - New York Community Bancorp ( NYCB/PA ) said on Tuesday it has changed its name to Flagstar Financial and its stock symbol to FLG. ...
UroGen Pharma Says US FDA Accepts New Drug Application for Bladder Cancer Treatment
UroGen Pharma Says US FDA Accepts New Drug Application for Bladder Cancer Treatment
Oct 17, 2024
05:04 PM EDT, 10/15/2024 (MT Newswires) -- UroGen Pharma ( URGN ) said Tuesday the US Food and Drug Administration accepted the new drug application for UGN-102 as an intravesical solution to treat low-grade intermediate-risk non-muscle invasive bladder cancer. The FDA has set a Prescription Drug User Fee Act target action date of June 13, 2025, the company said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved